Severe Respiratory Infections May Increase Lung Cancer Risk

Got story updates? Submit your updates here. ›

A study from the University of Virginia has found that severe respiratory infections like COVID-19 and influenza can alter the immune environment within the lungs, potentially creating conditions favorable for tumor growth and increasing the risk of developing lung cancer years later. Analysis of patient data shows a correlation between hospitalization for COVID-19 and a 24% increase in lung cancer incidence.

Why it matters

These findings prompt a re-evaluation of lung cancer screening strategies, with experts advocating for increased monitoring of individuals who have experienced severe respiratory infections, particularly those with existing risk factors like smoking. Early detection is crucial for successful lung cancer treatment, and the long-term implications of severe respiratory infections are still being investigated.

The details

The research indicates that severe infections don't just cause immediate damage; they can fundamentally change how the immune system functions within the lungs. Specifically, the study highlights alterations in the behavior of immune cells – neutrophils and macrophages – leading to chronic inflammation even after the initial infection has cleared. This persistent inflammation is believed to provide fertile ground for cancerous cells to develop. Researchers describe this as 'immune reprogramming,' making the lungs more susceptible to tumor formation in the future.

• The University of Virginia study was published on March 14, 2026.
• Analysis of human patient data showed an approximately 24% increase in lung cancer incidence among individuals hospitalized with COVID-19.

What’s next

Researchers emphasize the need for continued monitoring of patients who have recovered from COVID-19 or influenza to assess their long-term cancer risk. This proactive approach could lead to earlier diagnoses and improved outcomes.